Pathophysiology of acute graft-versus-host disease (Q35634710)

9 August 2017

1 reference

title

Pathophysiology of acute graft-versus-host disease (English)

1 reference

9 August 2017

1 reference

Pavan Reddy

1

1 reference

9 August 2017

publication date

1 December 2003

1 reference

9 August 2017

published in

Hematological Oncology

1 reference

9 August 2017

volume

21

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

149-161

1 reference

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

9 August 2017

cites work

1 reference

7 January 2021

Treatment of murine leukaemia with x-rays and homologous bone marrow. II

1 reference

7 January 2021

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation

1 reference

7 January 2021

HLA DNA typing and transplantation

1 reference

7 January 2021

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

7 January 2021

Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy

1 reference

7 January 2021

Does graft-versus-host disease attack epithelial stem cells?

1 reference

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

7 January 2021

Can graft endothelial cells initiate a host anti-graft immune response?

1 reference

7 January 2021

The danger model: a renewed sense of self

1 reference

7 January 2021

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.

1 reference

7 January 2021

Understanding the alloresponse: new approaches to graft-versus-host disease prevention.

1 reference

7 January 2021

Acute graft-versus-host disease does not require alloantigen expression on host epithelium

1 reference

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

7 January 2021

Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease

1 reference

7 January 2021

The instructive role of dendritic cells on T-cell responses

1 reference

7 January 2021

The immunological synapse.

1 reference

7 January 2021

Role of adhesion molecules in activation signaling in T lymphocytes

1 reference

7 January 2021

New strategies for preventing graft-versus-host disease

1 reference

7 January 2021

Tolerance and autoimmunity

1 reference

7 January 2021

Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

1 reference

7 January 2021

Mixed chimerism and transplant tolerance

1 reference

7 January 2021

T cell death and transplantation tolerance.

1 reference

7 January 2021

Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question

1 reference

7 January 2021

The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance

1 reference

7 January 2021

The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.

1 reference

7 January 2021

Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis

1 reference

7 January 2021

Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death

1 reference

7 January 2021

Role of the passive apoptotic pathway in graft-versus-host disease

1 reference

7 January 2021

Regulation of alloresponses after bone marrow transplantation using donor T cells expressing a thymidine kinase suicide gene

1 reference

7 January 2021

Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process

1 reference

7 January 2021

Transcription: tantalizing times for T cells

1 reference

7 January 2021

T-cell activation: a multidimensional signaling network.

1 reference

7 January 2021

Acute graft-vs-host disease: pathobiology and management

1 reference

7 January 2021

Critical role of interleukin-2 in the development of acute graft-versus-host disease.

1 reference

7 January 2021

Lethal murine graft-versus-host disease in the absence of detectable cytotoxic T lymphocytes

1 reference

7 January 2021

Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings

1 reference

7 January 2021

A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease

1 reference

7 January 2021

IL-15 and IL-2: a matter of life and death for T cells in vivo

1 reference

7 January 2021

Prolonged secretion of IL-15 in patients with severe forms of acute graft-versus-host disease after allogeneic bone marrow transplantation in children

1 reference

7 January 2021

Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages

1 reference

7 January 2021

The role of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency

1 reference

7 January 2021

Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease

1 reference

7 January 2021

Interferon gamma is required for activation-induced death of T lymphocytes

1 reference

7 January 2021

Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma

1 reference

7 January 2021

Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells

1 reference

7 January 2021

Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice

1 reference

7 January 2021

Role of interleukin-12 in acute graft-versus-host disease(1)

1 reference

7 January 2021

Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease

1 reference

7 January 2021

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

1 reference

7 January 2021

Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease

1 reference

7 January 2021

Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets

1 reference

7 January 2021

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

7 January 2021

CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT

1 reference

7 January 2021

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease

1 reference

7 January 2021

Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell

1 reference

7 January 2021

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

1 reference

7 January 2021

Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease

1 reference

7 January 2021

Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.

1 reference

7 January 2021

T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease

1 reference

7 January 2021

Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease

1 reference

7 January 2021

APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease

1 reference

7 January 2021

Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction

1 reference

7 January 2021

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

7 January 2021

Lymphocyte-mediated cytotoxicity.

1 reference

7 January 2021

The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice

1 reference

7 January 2021

Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation

1 reference

7 January 2021

Cytolytic pathways in haematopoietic stem-cell transplantation

1 reference

7 January 2021

Fas-mediated cholangiopathy in the murine model of graft versus host disease

1 reference

7 January 2021

Increased soluble Fas-ligand in sera of bone marrow transplant recipients with acute graft-versus-host disease

1 reference

7 January 2021

Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease

1 reference

7 January 2021

Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease path

1 reference

7 January 2021

T cells require TRAIL for optimal graft-versus-tumor activity

1 reference

7 January 2021

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

1 reference

7 January 2021

Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies

1 reference

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

7 January 2021

Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation

1 reference

7 January 2021

Influence of SHIP on the NK Repertoire and Allogeneic Bone Marrow Transplantation

1 reference

7 January 2021

Toll-like receptors: critical proteins linking innate and acquired immunity

1 reference

7 January 2021

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation

1 reference

7 January 2021

TUMOR NECROSIS FACTOR-?? NEUTRALIZATION REDUCES LUNG INJURY AFTER EXPERIMENTAL ALLOGENEIC BONE MARROW TRANSPLANTATION1

1 reference

7 January 2021

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect

1 reference

7 January 2021

Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens

1 reference

7 January 2021

Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia

1 reference

7 January 2021

Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation

1 reference

7 January 2021

Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.716

1 reference

9 August 2017

1 reference